Eculizumab in paroxysmal nocturnal hemoglobinuria

被引：0

作者：

Socie, Gerard ^{[1
]}

Varoqueaux, Nathalie ^{[2
]}

de Latour, Regis Peffault ^{[1
]}

机构：

[1] Hop St Louis, INSERM, AP HP, Serv Hematol Greffe,U728, F-75010 Paris, France

[2] Alexion Pharma France, Direct Affaires Med, F-75008 Paris, France

来源：

M S-MEDECINE SCIENCES | 2009年 / 25卷 / 12期

关键词：

COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A GENE; MICROPARTICLES; HEMOLYSIS; DISEASE;

D O I：

10.1051/medsci/200925121126

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Eculizumab in paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired clonal of the hematopoietic stem cell due to acquired mutation of the PIG-A gene. This results in the lack of two GPI-anchored membrane proteins involved in the inhibition of complement attack, thus explaining red cells hemolysis. The development of an anti-C5 monoclonal antibody (eculizumab) had profoundly modified the treatment of the the hemolytic form of the disease.

引用

页码：1126 / 1129

页数：4

共 50 条

[31] Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience
Czyz, Jaroslaw
Szukalski, Lukasz
Szukalska, Adriana
Budziszewska, Bozena Katarzyna
Lech-Maranda, Ewa
Zdziarska, Joanna
Sacha, Tomasz
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (06): : 707 - 710
[32] Successful treatment of noncirrhotic portal hypertension with eculizumab in paroxysmal nocturnal hemoglobinuria: A case report
Alexopoulou, Alexandra
Mani, Iliana
Tiniakos, Dina G.
Kontopidou, Flora
Tsironi, Ioanna
Noutsou, Marina
Pantelidaki, Helen
Dourakis, Spyros P.
WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (05) : 483 - 488
[33] Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab
Kang, Ka-Won
Moon, Hyemi
Lee, Byung-Hyun
Jeon, Min Ji
Yu, Eun Sang
Kim, Dae Sik
Lee, Se Ryeon
Sung, Hwa Jung
Choi, Chul Won
Kim, Byung Soo
Lee, Juneyoung
Park, Yong
ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1493 - 1503
[34] Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab
Kulasekararaj, Austin G.
Risitano, Antonio M.
Maciejewski, Jaroslaw P.
Notaro, Rosario
Browett, Peter
Lee, Jong Wook
Huang, Mingjun
Geffner, Michael
Brodsky, Robert A.
BLOOD, 2021, 138 (20) : 1928 - 1938
[35] Eculizumab in paroxysmal nocturnal haemoglobinuria
Escudero-Jimenez, Angel
Jesus Esteban-Mensua, Maria
Lopez-Briz, Eduardo
Jarque-Ramos, Isidro
Borrell-Garcia, Carmela
Luis Poveda-Andres, Jose
EJHP PRACTICE, 2011, 17 (01): : 31 - 35
[36] Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry
Hoechsmann, Britta
de Fontbrune, Flore Sicre
Lee, Jong Wook
Kulagin, Alexander D.
Hillmen, Peter
Wilson, Amanda
Marantz, Jing L.
Schrezenmeier, Hubert
EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (03) : 197 - 204
[37] PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PNH
Hamed, Hanan
LEUKEMIA RESEARCH, 2017, 61 : S6 - S6
[38] Paroxysmal nocturnal hemoglobinuria PNH
Hamed, Hanan
LEUKEMIA RESEARCH, 2018, 73 : S2 - S2
[39] Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan
Ooe, Yokiko
Nagai, Tomoko
SPRINGERPLUS, 2014, 3 : 1 - 5
[40] Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study
Debureaux, Pierre-Edouard
Kulasekararaj, Austin G.
Cacace, Fabiana
Silva, Bruno G. P.
Calado, Rodrigo T.
Barone, Federica
Sicre de Fontbrune, Flore
Prata, Pedro Henrique
Soret, Juliette
Sica, Michela
Notaro, Rosario
Scheinberg, Phillip
Mallikarjuna, Vasundhara
Gandhi, Shreyans
Large, Joanna
Risitano, Antonio M.
Peffault de Latour, Regis
Frieri, Camilla
BONE MARROW TRANSPLANTATION, 2021, 56 (10) : 2600 - 2602

← 1 2 3 4 5 →